156 related articles for article (PubMed ID: 10898827)
1. Pharmacokinetics and safety of tazarotene.
Menter A
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S31-5. PubMed ID: 10898827
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety review of tazarotene.
Marks R
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD; Matsumoto RM; Usansky JI
Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
[TBL] [Abstract][Full Text] [Related]
4. The role of tazarotene in the treatment of psoriasis.
Marks R
Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
7. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
Shalita AR; Chalker DK; Griffith RF; Herbert AA; Hickman JG; Maloney JM; Miller BH; Tschen EH; Chandraratna RA; Gibson JR; Lew-Kaya DA; Lue JC; Sefton J
Cutis; 1999 Jun; 63(6):349-54. PubMed ID: 10388959
[TBL] [Abstract][Full Text] [Related]
8. Optimizing treatment with topical tazarotene.
Guenther LC
Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
10. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
Lebwohl M
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
Webster GF; Berson D; Stein LF; Fivenson DP; Tanghetti EA; Ling M
Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
[TBL] [Abstract][Full Text] [Related]
12. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
Leyden J; Lowe N; Kakita L; Draelos Z
Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
[TBL] [Abstract][Full Text] [Related]
13. Clinical safety of tazarotene in the treatment of plaque psoriasis.
Marks R
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
[TBL] [Abstract][Full Text] [Related]
14. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene combination treatments in psoriasis.
Guenther L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
[TBL] [Abstract][Full Text] [Related]
16. Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
Guenther LC
Skin Therapy Lett; 2002 Mar; 7(3):1-4. PubMed ID: 12007011
[TBL] [Abstract][Full Text] [Related]
17. Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.
Attar M; Yu D; Ni J; Yu Z; Ling KH; Tang-Liu DD
J Pharm Sci; 2005 Oct; 94(10):2246-55. PubMed ID: 16136553
[TBL] [Abstract][Full Text] [Related]
18. Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris.
Jarratt M; Werner CP; Alió Saenz AB
Clin Drug Investig; 2013 Apr; 33(4):283-9. PubMed ID: 23456673
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
